ABVC BioPharma
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $795 | $0 | $1 | $1 |
Gross Profit | 795 | -80 | 1 | 1 |
EBITDA | -1,281 | -2,098 | -607 | |
EBIT | -1,286 | -2,179 | -721 | |
Net Income | -1,246 | -2,257 | -842 | 229 |
Net Change In Cash | 795 | 0 | 1 | 1 |
Free Cash Flow | -133 | -894 | -539 | -493 |
Cash | 192 | 1,076 | 759 | 248 |
Basic Shares | 23,256 | 17,386 | 14,968 | 13,137 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $509 | $152 | $969 | $355 |
Gross Profit | 508 | -149 | 683 | 350 |
EBITDA | -4,342 | -6,330 | -15,196 | -10,971 |
EBIT | -4,543 | -6,711 | -15,220 | -10,983 |
Net Income | -4,902 | -7,788 | -16,423 | -12,838 |
Net Change In Cash | 509 | 152 | 969 | 355 |
Free Cash Flow | -1,809 | -4,208 | -7,518 | -7,615 |
Cash | 863 | 716 | 1,391 | 5,828 |
Basic Shares | 11,673 | 4,335 | 3,166 | 2,505 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.05 |
2025-06-30 | -$0.13 |
2025-03-31 | $0.02 |
2024-09-30 | -$0.01 |
